Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Baymanon Sep 20, 2017 7:16pm
198 Views
Post# 26722917

RE:ProMetic has exactly what the FDA is looking for in an NDA

RE:ProMetic has exactly what the FDA is looking for in an NDAI hope you are right, but as I see it, they are still Eggs, and not Chickens, so don't count them yet.

And even if they do all hatch, they may not grow up the way you envision. ;-)

Good Luck to Us !!  

Gone til after the first FDA Decision !!


Biofinder wrote: This is for you, all you FUD posters:

I've read all I can find about ProMetic, and the FDA is pretty transparent about what they are expecting from a NDA:


1) Ryplazim has a 100% patient success rate in an unmet medical indication (i.e. there are no available drug treatments on the market today), exactly what the FDA is looking for,

2) pbi-4050 works well in a fibrosis indication (Alstrom Syndrome) where there is an unmet medical need, exactly what the FDA is looking for.

... again, do your own due diligence, and do what you want, I don't care, I got mine.







Bullboard Posts